Monoclonal-antibodies to human breast-cancer associated antigens

A Guha1, T Ghose, S Luner

  • 1DALHOUSIE UNIV,FAC MED,DEPT PATHOL,HALIFAX B3H 4H7,NS,CANADA. DALHOUSIE UNIV,FAC MED,DEPT RADIOL,HALIFAX B3H 4H7,NS,CANADA. DALHOUSIE UNIV,FAC MED,DEPT IMMUNOL & MICROBIOL,HALIFAX B3H 4H7,NS,CANADA.

Eleven murine monoclonal antibodies (MABs) were produced using human mammary cancer (HMC) cell lines as immunogens: None reacted with normal breast tissue, but each had a distinctive pattern of reactivity with HMC and benign proliferative lesions. Two MABs bound to overlapping epitopes of an M(r) 47,000 cell-surface antigen and were endocytosed: nine bound to secretable intracytoplasmic antigens(s). Four of the MABs immunoprecipitate antigens that upon reduction yielded an M(r) 73,000 moiety. None reacted with components of milk. All antigens were sensitive to trypsin, three to periodate oxidation but none to neuraminidase. One cell-surface-localizing MAB investigated, selectively localized in HMC xenografts.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...